Barclays »

Dogwood Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Dogwood Therapeutics (DWTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Dogwood Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dogwood Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dogwood Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $39 5 7.80

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Dogwood Therapeutics

Vanguard Group
Morgan Stanley
Geode Capital Management
Tower Research Capital
Activest Wealth Management
BlackRock
Bnp Paribas Arbitrage, Snc
Group One Trading
Barclays
SBI Securities

View all funds holding Dogwood Therapeutics